Abstract
P2.09-16 Aumolertinib Combined Intrathecal Chemotherapy for LM from EGFR-Mutated NSCLC and Prognostic Value of Dynamic Changes in cfDNA Profiles
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have